Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
基本信息
- 批准号:10001986
- 负责人:
- 金额:$ 31.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-21 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAffectAgeAgingAllelesAmericanAnimalsArthritisAttenuatedBindingBiochemicalBiological AssayBone DensityBone DiseasesBone ResorptionBone remodelingCSF1R geneCell NucleusCellsChemicalsControl AnimalCytoplasmDataDeveloped CountriesDiseaseEconomic BurdenEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessEstrogen ReplacementsEstrogen TherapyEstrogensEventExhibitsFractureFrightGenetic TranscriptionGoalsHealthcare SystemsHip FracturesHistonesHospitalizationHumanIn VitroIndividualKnock-outKnockout MiceKnowledgeLeucineLoxP-flanked alleleMacrophage Colony-Stimulating FactorMaintenanceMeasuresModelingMolecularMorbidity - disease rateMusNuclearOperative Surgical ProceduresOsteoclastsOsteogenesisOsteopeniaOsteoporosisOvariectomyPH DomainPathway interactionsPeriodontitisPhenotypePhosphorylationPopulationProcessProtein phosphatasePublishingQuality of lifeReceptor Protein-Tyrosine KinasesRoleSerious Adverse EventTestingTranslatingUnited StatesWild Type MouseWomanWorkbasebonebone massconditional knockoutcortical bonefracture riskhigh riskin vivoinnovationmenmicroCTmortalitymutantnovelosteoclastogenesisosteoporosis with pathological fractureprogenitorpromoterprotective effectpublic health relevancereconstitutionresponsesocialstem cellssubstantia spongiosatumor
项目摘要
Abstract
Osteoporosis is a significant cause of morbidity and mortality in developed countries. In the United States, over
8 million women and 2 million men age 50 and above have osteoporosis. Another 51 million women and 35
million men have osteopenia. This translates into a higher risk of fracture within this population, with half of all
women and one quarter of men projected to suffer a low bone mass-related fracture. Osteoporotic fractures
impart deleterious consequences, including increased hospitalization and mortality. An estimated 25% of
individuals will die within one year of a hip fracture. Despite the availability of anti-resorptive therapies that
decrease fracture rates, their prescription and use have declined significantly due to fears of extremely rare but
serious adverse events. This has created a treatment gap that threatens the quality of life of millions of
Americans and poses a tremendous challenge to our healthcare systems and economy. It also highlights the
need to better understand osteoclast formation and function. The goal of this five-year application is to
determine the role of the protein phosphatase Phlpp1 in osteoclastogenesis and bone density and to define the
epigenetic mechanisms required for Phlpp1 to modulate Csf1r (c-fms) expression and osteoclastogenesis. The
five-year deliverables are: 1) definition of the functions of Phlpp1 in osteoclast progenitor cells, 2)
characterization of the cytosolic functions of Phlpp1 that influence M-CSF responsiveness, Csfr1 expression
and osteoclast function, and 3) determination of the nuclear functions of Phlpp1 that influence Csfr1
transcription and osteoclastogenesis. This work will increase our understanding of how Phlpp1 and associated
pathways affect bone density.
摘要
骨质疏松症是发达国家发病率和死亡率的重要原因。在美国,在
800万50岁以上的女性和200万50岁以上的男性患有骨质疏松症。另有5100万妇女和35
百万男性患有骨质疏松症。这意味着这一人群中骨折的风险更高,
妇女和四分之一的男子预计将遭受低骨量相关骨折。骨质疏松性骨折
造成有害后果,包括增加住院率和死亡率。据估计,
每个人都会在髋骨骨折后一年内死亡。尽管有抗吸收疗法,
减少骨折率,他们的处方和使用显着下降,由于担心极其罕见,但
严重不良事件。这造成了一个治疗差距,威胁到数百万人的生活质量。
这对我们的医疗保健系统和经济构成了巨大的挑战。它还强调了
需要更好地了解破骨细胞的形成和功能。这五年申请的目标是
确定蛋白磷酸酶Phlpp 1在破骨细胞生成和骨密度中的作用,
Phlpp 1调节Csf 1 r(c-fms)表达和破骨细胞生成所需的表观遗传机制。的
五年的交付成果是:1)破骨细胞祖细胞中Phlpp 1功能的定义,2)
Phlpp 1影响M-CSF反应性、Csfr 1表达的胞浆功能的表征
和破骨细胞功能; 3)测定影响Csfr 1的Phlpp 1的核功能
转录和破骨细胞生成。这项工作将增加我们对Phlpp 1和相关的
影响骨密度的通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth W Bradley其他文献
Elizabeth W Bradley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth W Bradley', 18)}}的其他基金
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
- 批准号:
10237904 - 财政年份:2017
- 资助金额:
$ 31.87万 - 项目类别:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
- 批准号:
9761459 - 财政年份:2017
- 资助金额:
$ 31.87万 - 项目类别:
Epigenetic Regulation of Phlpp1 in Cartilage Development and Regeneration
Phlpp1 在软骨发育和再生中的表观遗传调控
- 批准号:
8893005 - 财政年份:2014
- 资助金额:
$ 31.87万 - 项目类别:
Runx2 and Axin2 Interactions During Bone Formation
Runx2 和 Axin2 在骨形成过程中的相互作用
- 批准号:
8334718 - 财政年份:2011
- 资助金额:
$ 31.87万 - 项目类别:
Runx2 and Axin2 Interactions During Bone Formation
Runx2 和 Axin2 在骨形成过程中的相互作用
- 批准号:
8195738 - 财政年份:2011
- 资助金额:
$ 31.87万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant